Globally there are estimated to be more than 20 million people living with a spinal cord injury (SCI) and nearly a million new cases each year.
SCI interrupts the flow of information between the brain and the rest of the body and can result in permanent paralysis, loss of sensation and an inability to regulate functions like breathing and blood pressure, seriously diminishing quality of life.
Despite important research progress, there is still no clinically available solution to repair the spinal cord.
The collaborative Wyss Center, CHUV, NeuroRestore, EPFL team at Campus Biotech is designing a gene therapy that can be combined with neuroprosthetic rehabilitation to improve recovery, restore walking and enable people to restart daily activities after spinal cord injury.
A new Wyss Center - University of Geneva collaboration aims to decode imagined speech directly from the brain using novel implanted electrodes and new algorithms.
The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.
Symposium: As the BCI community shifts its focus to clinical studies for patient benefit, join us to hear from researchers and companies working together at the forefront of BCI development discussing paths to translation and BCI home-use.
We welcome new opportunities to exchange ideas and to explore collaborations
Collaborate with usWe are searching for innovative and driven people to make a difference
Join our teamWe welcome feedback on our projects
Provide feedback
